Champions Oncology in vivo testing solutions includes high-throughput drug screening and model selection platforms for the preclinical assessment of novel anticancer agents, to help guide drug development decisions and clinical trial design.
Utilize commercially-available or custom cancer cell lines to evaluate tumor growth inhibition, as well as syngeneic models for the evaluation of immune-oncology agents, to more accurately and effectively gain predictive insight into clinical trial responses.
Answer key question about the viability of compounds in development, their suitability as single or combination drugs, which agent in your pipeline has the most effect in a specific tumor type, what biomarkers can be used for clinical patient stratification, and more with Champions Oncology preclinical research and development solutions.
Contact us to learn more about Champions Oncology in vivo testing services.
To learn about Champions Oncology Translational Solutions, click here.
To learn about Champions Oncology Clinical Solutions, click here.
To learn more about establishing a Strategic Partnership with Champions Oncology, click here.